Tovet (Emollient Formulation) Drug Interactions: 284 Major
Tovet (Emollient Formulation) (Clobetasol Propionate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tovet (Emollient Formulation). Always confirm against the full prescribing information.
100 interactions
Acarbose
The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Acarbose.
Level 1 evidence
Acenocoumarol
Clobetasol propionate may increase the anticoagulant activities of Acenocoumarol.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Acetylsalicylic acid.
Level 1 evidence
Albendazole
The metabolism of Albendazole can be increased when combined with Clobetasol propionate.
Level 2 evidence
Albuterol
The risk or severity of hypokalemia can be increased when Clobetasol propionate is combined with Albuterol.
Level 2 evidence
Alfentanil
The metabolism of Alfentanil can be increased when combined with Clobetasol propionate.
Level 2 evidence
Almasilate
The bioavailability of Clobetasol propionate can be decreased when combined with Almasilate.
Level 2 evidence
Alogliptin
The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Alogliptin.
Level 1 evidence
Alprazolam
The metabolism of Alprazolam can be increased when combined with Clobetasol propionate.
Level 2 evidence
Aluminium phosphate
The bioavailability of Clobetasol propionate can be decreased when combined with Aluminium phosphate.
Level 2 evidence
Aluminum hydroxide
The bioavailability of Clobetasol propionate can be decreased when combined with Aluminum hydroxide.
Level 2 evidence
Ambrisentan
The metabolism of Ambrisentan can be increased when combined with Clobetasol propionate.
Level 2 evidence
Enter your NPI to unlock 48 major interactions for Tovet (Emollient Formulation)
Tovet (Emollient Formulation) (Clobetasol Propionate) has 731 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Tovet (Emollient Formulation) (Clobetasol Propionate) has 284 major, 357 moderate, and 90 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Tovet (Emollient Formulation). Always confirm against the full prescribing information.